A. Marchiori

发表

Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow‐up

P. Prandoni, R. Pesavento, A. Visoná, 2009, Journal of thrombosis and haemostasis : JTH.

A novel dysfunctional protein C (Protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg‐1 results in a strongly reduced affinity for binding of Ca++

V. Kakkar, P. Simioni, A. Girolami, 1993, British journal of haematology.

Physical activity and PDE5 inhibitors in the treatment of erectile dysfunction: results of a randomized controlled study.

A. Marchiori, G. Maio, Salim Saraeb, 2010, The journal of sexual medicine.

Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism

M. Prins, P. Prandoni, E. Bernardi, 2002, Annals of Internal Medicine.

Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome

M. Prins, P. Prandoni, B. Hutten, 2005, Journal of thrombosis and haemostasis : JTH.

The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study

M. Prins, P. Prandoni, E. Bernardi, 2004, BMJ : British Medical Journal.

Congenital deficiencies and abnormalities of prothrombin.

A. Bertomoro, A. Girolami, B. Girolami, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Below-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome

M. Prins, P. Prandoni, E. Bernardi, 2004, Annals of Internal Medicine.

Anticoagulant Treatment in Patients with Cancer and Venous Thrombosis Recurrent Venous Thromboembolism and Bleeding Complications During

M. Prins, P. Prandoni, E. Bernardi, 2013 .

Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism

P. Prandoni, C. Bova, A. Marchiori, 2006, Thrombosis and Haemostasis.

The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.

P. Prandoni, E. Bernardi, P. Simioni, 1997, Haematologica.

High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study.

P. Prandoni, F. Verlato, G. Andreozzi, 2002, Haematologica.

Risk of recurrent venous thomboembolism--expanding the frontier.

M. Prins, A. Marchiori, 2002, Thrombosis and haemostasis.

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

Paolo Prandoni, Sabino Iliceto, Vittorio Pengo, 2004, The New England journal of medicine.

Upper Extremity Deep Vein Thrombosis: Risk Factors, Diagnosis, and Management

P. Prandoni, E. Bernardi, B. Girolami, 2001, Seminars in vascular medicine.

The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.

Paolo Prandoni, M. Prins, P. Prandoni, 2007, Haematologica.

Factor V Leiden (Activated Protein C Resistance) Versus Factor V Deficiency in Padua, Italy

P. Simioni, A. Girolami, E. Zanon, 1998 .

Hemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classification.

P. Simioni, A. Girolami, B. Girolami, 1998, Blood reviews.

An association between atherosclerosis and venous thrombosis.

M. Prins, P. Prandoni, E. Bernardi, 2003, The New England journal of medicine.

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Paolo Prandoni, Antonio Girolami, Paolo Simioni, 2002, Blood.

Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.

P. Prandoni, A. Marchiori, M. Carnovali, 2004, Archives of internal medicine.

Use of an Algorithm for Administering Subcutaneous Heparin in the Treatment of Deep Venous Thrombosis

P. Prandoni, E. Bernardi, A. Girolami, 1998, Annals of Internal Medicine.

Elastic stockings, hydroxyethylrutosides or both for the treatment of post-thrombotic syndrome

P. Prandoni, D. Tormene, A. Marchiori, 2005, Thrombosis and Haemostasis.

Superficial vein thrombosis: risk factors, diagnosis, and treatment.

P. Prandoni, A. Marchiori, L. Mosena, 2006, Seminars in thrombosis and hemostasis.

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

M. Prins, P. Prandoni, E. Bernardi, 2002, Blood.